Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-β particle in type 2 diabetic patients

Clinica Chimica Acta

Volumn 279, Issue 1-2, 1999, Pages 1-14

  Brites, Fernando D ^a   Cavallero, Elisabeth ^b   De Geitere, Catherine ^c   Nicolaïew, Nathalie ^b   Jacotot, Bernard ^b   Rosseneu, Maryvone ^d   Fruchart, Jean Charles ^c   Wikinski, Regina L ^a   Castro, Graciela R ^c  

^a Depto Bioquim Clin Fac F   (Argentina)

^b Serv Med Nucl   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

Apolipoprotein A I; Cholesterol efflux; Postprandial lipemia; Pre HDL; Type 2 diabetes

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN A; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; HUMAN; HYPERLIPIDEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL;

ADULT; ANIMALS; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; CHOLESTEROL; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FASTING; HEMOFILTRATION; HUMANS; LIPOPROTEIN(A); LIVER NEOPLASMS, EXPERIMENTAL; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; PROTEIN PRECURSORS; RATS; TRIGLYCERIDES; TUMOR CELLS, CULTURED;

EID: 0032957769     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00155-7     Document Type: Article

References (26)

1. Brown W.V. Lipoprotein disorders in diabetes mellitus. Med Clin N Am. 78:1994;143-161.
2. Cavallero E., Dachet C., Neufcour D., Wirquin E., Matteand D., Jacotot B. Postprandial amplification of lipoprotein abnomalities in controlled type II diabetic subjects: relationship to postprandial lipemia and C-peptide/glucagon levels. Metabolism. 43:1994;270-278.
3. Cheung M.C., Albers J.J. Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. J. Biol Chem. 259:1984;12201-12209.
4. Lagrost L., Dengremont C., Athias A., De Geitere C., Fruchart J.C., Lallemant C., Gambert P., Castro G. Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles. Particles containing various proportions of apolipoproteins A-I and A-II. J Biol Chem. 270:1995;13004-13009.
5. Castro G.R., Fielding C.J. Early incorporation of cell-derived cholesterol into pre-β-migrating high density lipoprotein. Biochemistry. 27:1988;25-29.
6. Barbaras R., Puchois P., Fruchart J.C., Ailhaud G. Cholesterol efflux from cultured adipose cells is mediated by LpA-I particles but not by LpA-I:A-II particles. Biochem Biophys Res Commun. 142:1987;63-69.
7. Barkia A., Puchois P., Ghalim N., Torpier G., Barbaras R., Ailhaud G., Fruchart J.C. Differential role of apoprotein A-I-containing-particles in cholesterol efflux from adipose cells. Atherosclerosis. 87:1991;135-146.
8. Oikawa S., Mendez A.J., Oram J.F., Bierman E.L., Cheung M.C. Effects of high-density lipoprotein particles containing apo A-I, with or without apo A-II, on intracellular cholesterol efflux. Biochim Biophys Acta. 1165:1993;327-334.
9. Johnson W.J., Kilsdonk E.P.C., van Tol A., Phillips M.C., Rothblat G.H. Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: LP-AI and LP-AI/AII. J Lipid Res. 32:1991;1993-2000.
10. Cavallero E., Brites F., Delfly B., Nicolaïew N., Decossin C., De Geitere C., Fruchart J.C., Wikinski R., Jacotot B., Castro G. Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles. Arterioscler Thromb Vasc Biol. 15:1995;2130-2135.
11. Fielding C.J., Fielding P.E. Evidence for a lipoprotein carrier in human plasma catalyzing sterol efflux from cultured fibroblasts and its relationship to lecithin:cholesterol acyltransferase. Proc Natl Acad Sci USA. 78:1981;3911-3914.
12. De la Llera Moya M., Atger V., Paul J.L., Fournier N., Moatti N., Giral P., Friday K.E., Rothblat G. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Arterioscler Thromb. 14:1994;1056-1065.
13. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 34:1955;1345-1353.
14. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem. 193:1951;265-275.
15. Brinton E.A., Eisenberg S., Breslow J.L. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. J Clin Invest. 87:1991;536-544.
16. Aalto-Setälä K., Fisher E.A., Chen X., Chajek-Shaul T., Hayek T., Zechner R., Walsh A., Ramakrishnan R., Ginsberg H.N., Breslow J.L. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. J Clin Invest. 90:1992;1889-1900.
17. Fruchart J.C., Ailhaud G. Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance. Clin Chem. 38:1992;793-797.
18. Forte T.M., McCall M.R. The role of apolipoprotein A-I-containing lipoproteins in atherosclerosis. Curr Opin Lipidol. 5:1994;354-364.
19. Syvänne M., Kahri J., Virtanen K.S., Taskinen M.R. HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus. Circulation. 92:1995;364-370.
20. Brinton E.A., Eisenberg S., Breslow J.L. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Arterioscler Thromb. 14:1994;707-720.
21. Hopkins G.J., Chang L.B.F., Barter P.J. Role of lipid transfer in the formation of subpopulations of small high density lipoproteins. J Lipid Res. 26:1985;218-229.
22. Hopkins G.J., Barter P.J. Role of triglyceride-rich lipoproteins and hepatic lipase in determining the particle size and composition of high density lipoproteins. J Lipid Res. 27:1986;1265-1277.
23. Harno K., Nikkila E.A., Kuusi T. Plasma HDL cholesterol and post heparin plasma hepatic endothelial lipase activity: relationship to obesity and non-insulin dependent diabetes. Diabetologia. 19:1980;281-289.
24. Syvänne M., Ahola M., Lahdenperä S., Kahri J., Kuusi T., Virtanen K.S., Taskinen M.R. High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease. J Lipid Res. 36:1995;573-582.
25. Castro G.R., Fielding C.J. Effects of postprandial lipemia on plasma cholesterol metabolism. J Clin Invest. 75:1985;874-882.
26. Horowitz B.S., Goldberg I.J., Merab J., Vanni T.M., Ramakrishnan R., Ginsberg H.N. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. J Clin Invest. 91:1993;1743-1752.